De Clercq E - Search Results

1

Synthesis and antiviral activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil against HIV-1.

Maruyama T, Kozai S, Demizu Y, Witvrouw M, Pannecouque C, Balzarini J, Snoeck R, Andrei G, De Clercq E. Maruyama T, et al. Among authors: de clercq e. Nucleic Acids Symp Ser (Oxf). 2004;(48):3-4. doi: 10.1093/nass/48.1.3. Nucleic Acids Symp Ser (Oxf). 2004. PMID: 17150449

2

A mercapto analogue of 5'-noraristeromycin.

Das SR, Schneller SW, Balzarini J, De Clercq E. Das SR, et al. Among authors: de clercq e. Bioorg Med Chem. 2002 Feb;10(2):457-60. doi: 10.1016/s0968-0896(01)00271-1. Bioorg Med Chem. 2002. PMID: 11741794

3

Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.

Sienaert R, Naesens L, Brancale A, De Clercq E, McGuigan C, Balzarini J. Sienaert R, et al. Among authors: de clercq e. Mol Pharmacol. 2002 Feb;61(2):249-54. doi: 10.1124/mol.61.2.249. Mol Pharmacol. 2002. PMID: 11809847

4

Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.

Auwerx J, North TW, Preston BD, Klarmann GJ, De Clercq E, Balzarini J. Auwerx J, et al. Among authors: de clercq e. Mol Pharmacol. 2002 Feb;61(2):400-6. doi: 10.1124/mol.61.2.400. Mol Pharmacol. 2002. PMID: 11809865

5

Influence of 2-substituent on the activity of imidazo[1,2-a] pyridine derivatives against human cytomegalovirus.

Mavel S, Renou JL, Galtier C, Allouchi H, Snoeck R, Andrei G, De Clercq E, Balzarini J, Gueiffier A. Mavel S, et al. Among authors: de clercq e. Bioorg Med Chem. 2002 Apr;10(4):941-6. doi: 10.1016/s0968-0896(01)00347-9. Bioorg Med Chem. 2002. PMID: 11836102

6

New 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane thiosemicarbazones-thiocarbonohydrazones: cell growth inhibitory, antiviral and antimicrobial activity evaluation.

Kolocouris A, Dimas K, Pannecouque C, Witvrouw M, Foscolos GB, Stamatiou G, Fytas G, Zoidis G, Kolocouris N, Andrei G, Snoeck R, De Clercq E. Kolocouris A, et al. Among authors: de clercq e. Bioorg Med Chem Lett. 2002 Mar 11;12(5):723-7. doi: 10.1016/s0960-894x(01)00838-1. Bioorg Med Chem Lett. 2002. PMID: 11858989

7

Synthesis of new covalently bound kappa-carrageenan-AZT conjugates with improved anti-HIV activities.

Vlieghe P, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Kraus JL. Vlieghe P, et al. Among authors: de clercq e. J Med Chem. 2002 Mar 14;45(6):1275-83. doi: 10.1021/jm010969d. J Med Chem. 2002. PMID: 11881996

8

Synthesis and biological activity of some 4-substituted 1-[1-(2,3-dihydroxy-1-propoxy)methyl-1,2,3-triazol-(4 & 5)-ylmethyl]-1H-pyrazolo[3,4-d]pyrimidines.

Moukha-chafiq O, Taha ML, Lazrek HB, Vasseur JJ, Pannecouque C, Witvrouw M, De Clercq E. Moukha-chafiq O, et al. Among authors: de clercq e. Farmaco. 2002 Jan;57(1):27-32. doi: 10.1016/s0014-827x(01)01152-1. Farmaco. 2002. PMID: 11902642

9

6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity.

Holý A, Votruba I, Masojídková M, Andrei G, Snoeck R, Naesens L, De Clercq E, Balzarini J. Holý A, et al. Among authors: de clercq e. J Med Chem. 2002 Apr 25;45(9):1918-29. doi: 10.1021/jm011095y. J Med Chem. 2002. PMID: 11960502

10

New treatments for genital herpes.

Snoeck R, De Clercq E. Snoeck R, et al. Among authors: de clercq e. Curr Opin Infect Dis. 2002 Feb;15(1):49-55. doi: 10.1097/00001432-200202000-00009. Curr Opin Infect Dis. 2002. PMID: 11964906 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,295 results

Search Page

Filters